Kaiser Permanente neurologist and research scientist is dedicated to increasing awareness about stroke on World Stroke Day — Oct. 29 — and all year round.
The Kaiser Permanente Division of Research postdoctoral research program drew one of its largest-ever classes of fellows this year, building the strength of DOR's research portfolio. Seven fellows cover fields from diet to dementia, cancer to clinical informatics, to women's and children's health, and more.
The Patient-Centered Outcomes Research Institute-funded study will be co-led by research scientist and gastroenterologist Theodore R. Levin, MD, and focus on older adults with low-risk polyps.
A Kaiser Permanente analysis of more than 100,000 pregnancies in Northern California finds a 25% increase in the rate of cannabis use early in pregnancy after the pandemic began in spring 2020.
Physician researcher Robert Chang, MD, used a Kaiser Permanente Northern California patient registry to determine a patient's risk of having a large abdominal aortic aneurysm rupture.
KP Research Radio talks to Ai Kubo, PhD, MPH, about her research into why girls are starting puberty earlier than they have in the past, risks associated with early puberty — and potential interventions.
Kaiser Permanente researchers are surveying pregnant women during the pandemic and the first findings from the survey show a low percentage of COVID-19 infections, with higher prevalence among younger women, Hispanic women, and those living in neighborhoods with greater economic deprivation.
Federal and Kaiser Permanente researchers combing the health records of 6.2 million patients found no serious health effects that could be linked to the 2 mRNA COVID-19 vaccines.
The number of teens being seen at Kaiser Permanente Northern California emergency departments (ED) for suicidal thoughts and behaviors did not increase significantly during the COVID-19 pandemic, though specific groups of teens may have sought care at higher rates during late 2020. The findings were reported Sept. 1 in JAMA Psychiatry.
A large, detailed look by Kaiser Permanente researchers at patients taking HIV-prevention drug therapy finds strong adherence soon after patients get the prescription, but less consistent use thereafter, particularly among groups considered high priority for receiving the medication.